A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
A Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke
Lead SponsorRock Creek Pharmaceuticals, Inc.
StatusCompleted No Results Posted
Indication/ConditionTobacco Use Disorder Smoking
A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke
Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.
lozenge made of dietary supplements
lozenge made of compressed cured tobacco extract
Inclusion Criteria: Healthy adult smokers Smoking for at least 5 years Smoking at least one (1) pack of cigarettes a day Exclusion Criteria: Allergy to lozenge components